Komori
Governance4502Takeda Pharmaceutical Company LimitedPharmaceuticals

Articles of Incorporation 2026/06/29

The Articles of Incorporation amended on 29 June 2026 establish an Audit and Supervisory Committee as a corporate body and set the maximum number of directors, as well as basic matters concerning general meetings of shareholders and electronic provision measures. The specific changes from the previous Articles of Incorporation cannot be determined from this document alone.

Worth reading
73In focus
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Company with an Audit and Supervisory Committee
Number of directorsUp to 12 directors, excluding directors who are Audit and Supervisory Committee members, and up to 4 directors who are Audit and Supervisory Committee members (16 in total); number of outside directors: Not disclosed
Committee1
Audit and Supervisory Committee
Changes this time

No changes from the previous articles of incorporation are stated.

Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit and Supervisory Committee
Number of directorsUp to 12 directors, excluding directors who are Audit and Supervisory Committee members, and up to 4 directors who are Audit and Supervisory Committee members (16 in total); number of outside directors: Not disclosed
CommitteeAudit and Supervisory Committee (proportion of outside members: Not disclosed)
Changes this timeNo changes from the previous articles of incorporation are stated.
Items this document does not state (4)
Number of independent officersPolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The reason for amending the Articles of Incorporation is not stated.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Articles of Incorporation 2026/06/29 | Takeda Pharmaceutical Company Limited (4502) timely disclosure | Komori